ZYNERBA PHARMACEUTICALS, INC. Retained Earnings
ZYNERBA PHARMACEUTICALS, INC. had Retained Earnings of -$295.41 million as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2023-08-14
- 2023-06-30: Retained Earnings (Accumulated Deficit) -$295.41M.
- 2023-03-31: Retained Earnings (Accumulated Deficit) -$284.63M.
- 2022-12-31: Retained Earnings (Accumulated Deficit) -$274.52M.
- 2022-09-30: Retained Earnings (Accumulated Deficit) -$266.50M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2023-06-30 | -$295.41M 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$284.63M 10-Q · filed 2023-05-15 |
| 2022-12-31 | -$274.52M 10-Q · filed 2023-08-14 |
| 2022-09-30 | -$266.50M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$257.83M 10-Q · filed 2022-08-10 |
| 2022-03-31 | -$247.97M 10-Q · filed 2022-05-16 |
| 2021-12-31 | -$239.48M 10-K · filed 2023-03-28 |
| 2021-09-30 | -$230.67M 10-Q · filed 2021-11-15 |
| 2021-06-30 | -$220.08M 10-Q · filed 2021-08-09 |
| 2021-03-31 | -$210.13M 10-Q · filed 2021-05-12 |
| 2020-12-31 | -$202.17M 10-K · filed 2022-03-01 |
| 2020-09-30 | -$192.55M 10-Q · filed 2020-11-09 |
| 2020-06-30 | -$183.51M 10-Q · filed 2020-08-10 |
| 2020-03-31 | -$163.17M 10-Q · filed 2020-05-11 |
| 2019-12-31 | -$150.84M 10-K · filed 2021-03-10 |
| 2019-09-30 | -$140.12M 10-Q · filed 2019-11-06 |
| 2019-06-30 | -$138.17M 10-Q · filed 2019-08-06 |
| 2019-03-31 | -$127.04M 10-Q · filed 2019-05-08 |
| 2018-12-31 | -$117.89M 10-K · filed 2020-03-10 |
| 2018-09-30 | -$110.10M 10-Q · filed 2018-11-08 |
| 2018-06-30 | -$102.29M 10-Q · filed 2018-08-02 |
| 2018-03-31 | -$90.29M 10-Q · filed 2018-05-08 |
| 2017-12-31 | -$77.98M 10-K · filed 2019-03-11 |
| 2017-09-30 | -$69.86M 10-Q · filed 2017-11-14 |
| 2017-06-30 | -$61.55M 10-Q · filed 2017-08-01 |
| 2017-03-31 | -$53.23M 10-Q · filed 2017-05-09 |
| 2016-12-31 | -$45.97M 10-K · filed 2018-03-12 |
| 2016-09-30 | -$39.07M 10-Q · filed 2016-11-14 |
| 2016-06-30 | -$33.09M 10-Q · filed 2016-08-11 |
| 2016-03-31 | -$26.86M 10-Q · filed 2016-05-12 |
| 2015-12-31 | -$22.58M 10-K · filed 2017-03-27 |
| 2015-09-30 | -$17.14M 10-Q · filed 2015-11-12 |
| 2015-06-30 | -$13.15M 10-Q · filed 2015-08-27 |
| 2014-12-31 | -$10.03M 10-K · filed 2016-03-14 |